Losartan Potassium Tablet, Film Coated
Product Images NDC 71335-1235

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 71335-1235). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713351235)

Label (Lbl713351235)
This is a medication label for Losartan Potassium 100mg tablets produced by Aurobindo Pharma Limited. Losartan is an FDA-approved medication to treat hypertension, commonly marketed under the brand name Cozaar. The tablets are oval-shaped and green with the imprint of "E47." The label provides instructions to store the medication at a room temperature of 20-25°C (68°-77°F) and keep it out of the reach of children. It also includes information on the quantity of tablets and the expiration date.*
FDA Label Image

Figure1 (Losartan Fig1)

Figure1 (Losartan Fig1)
This appears to be a partial graph or figure, with labels for two medications, Atenolol and Losartan Potassium, followed by the text "Adjusted Risk Reduction: 13%, p=" and a series of numbers indicating months. Without more context or information, it's not clear what the graph or figure is representing or what the significance of the data is.*
FDA Label Image

Figure2 (Losartan Fig2)

FDA Label Image

Figure 3 (Losartan Fig3)

Figure 3 (Losartan Fig3)
Figure 3 shows the primary endpoint events within different demographic subgroups. However, due to the poor quality of the text, it's difficult to interpret specific details.*
FDA Label Image

Figure-4 (Losartan Fig4)

Figure-4 (Losartan Fig4)
This appears to be a table showing the percentage of patients with an event for two groups (Losttan Potassium and Placebo), along with the Risk Reduction and p-value. It is unclear what the event is, but the Risk Reduction is given as 16.1% with a p-value of 0.022.*
FDA Label Image

Chemical Structure (Losartan Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.